Vimarsana
Biggest News Aggregation in the World

Page 21 - Equity Strategy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Equity Strategy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Equity Strategy Today - Breaking & Trending Today

Mankind Pharma lists at 20% premium, surges nearly 30% in debut trading - Vimarsana News

Mankind Pharma lists at 20% premium, surges nearly 30% in debut trading

In debut trading, shares of the Manforce condom maker jumped as much as 29.62 per cent to touch a high of Rs 1,399.95 on BSE.

Mankind Pharma IPO: After a giant leap by Mankind Pharma, should you too take a leap of faith? - Vimarsana News

Mankind Pharma IPO: After a giant leap by Mankind Pharma, should you too take a leap of faith?

Mankind Pharma IPO: The company is almost entirely focussed in India. The domestic market contributed 97.60 percent to the company's revenue from operations in FY22

Mankind Pharma Makes Stock Market Debut With 20% Premium - Vimarsana News

Mankind Pharma Makes Stock Market Debut With 20% Premium

The pharmaceutical and consumer health company’s over Rs 4,300 crore initial public offering (IPO) was open for subscription during April 25-27.

Source: india.com
Mankind Pharma surges 32% on debut despite market volatility - Vimarsana News

Mankind Pharma surges 32% on debut despite market volatility

Given its healthy financial track record, domestic focus and extensive network, Mankind is likely to continue doing well, Hemang Jani of Motilal Oswal believes.

Demat account openings hit lowest since Dec 2020 at 1.6 million as volatility continues - Vimarsana News

Demat account openings hit lowest since Dec 2020 at 1.6 million as volatility continues

Some analysts blamed the ongoing crisis in the IT sector for the loss of interest in demat accounts. IT, which has historically been a key contributor to new account openings, is in throes of severe uncertainty, leading to large-scale downsizing and pay cuts